Item 8.01 Other Information.
OnJanuary 22, 2020 ,SI-BONE, Inc. (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement") withMorgan Stanley & Co. LLC andBofA Securities, Inc. , representatives of the several underwriters (the "Underwriters"), and certain shareholders of the Company (the "Selling Shareholders") relating to the offering and sale (the "Offering") of 4,300,000 shares of the Company's common stock, par value$0.0001 per share. Of these shares, 1,809,947 shares were offered by the Selling Shareholders, and 2,490,053 shares were offered by the Company. The price to the public in the Offering is$21.50 per share of common stock. Pursuant to the Underwriting Agreement, the Underwriters have a 30-day option to purchase up to an additional 645,000 shares of common stock from the Company on the same terms and conditions. The Offering is scheduled to close onJanuary 27, 2020 , subject to the satisfaction of customary closing conditions. The shares of common stock are listed on The Nasdaq Global Market. The Offering is being made pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-235714) filed with theSecurities and Exchange Commission (the "SEC") onDecember 27, 2019 , and declared effective onJanuary 2, 2020 . The Company filed with theSEC a preliminary prospectus supplement, datedJanuary 21, 2020 , and a final prospectus supplement, datedJanuary 22, 2020 , relating to the offer and sale of the shares. Morgan Stanley andBofA Securities are acting as joint book-running managers.Canaccord Genuity LLC andJMP Securities LLC are acting as co-managers. The Underwriting Agreement contains customary representations, warranties and agreements by the Company and the Selling Shareholders, customary conditions to closing, indemnification obligations of the Company, the Selling Shareholders and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties. The Underwriting Agreement is filed as Exhibit 1.1 hereto. The foregoing description of the terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit. A copy of the opinion ofCooley LLP relating to the shares in the Offering is attached as Exhibit 5.1 hereto.
Item 9.01 - Financial Statements and Exhibits.
Exhibit No. Description Underwriting Agreement, dated January 22, 2020 , by and among the Company, Morgan Stanley & Co. LLC and BofA Securities, Inc., as 1.1 representatives of the several underwriters named on Schedule II thereto, and certain shareholders of the Company named on Schedule I thereto. 5.1 Opinion of Cooley LLP 23.1 Consent of Cooley LLP (contained in Exhibit 5.1)
--------------------------------------------------------------------------------
© Edgar Online, source